304 related articles for article (PubMed ID: 34434170)
21. A novel peripheral cannabinoid receptor 1 antagonist, BPR0912, reduces weight independently of food intake and modulates thermogenesis.
Hsiao WC; Shia KS; Wang YT; Yeh YN; Chang CP; Lin Y; Chen PH; Wu CH; Chao YS; Hung MS
Diabetes Obes Metab; 2015 May; 17(5):495-504. PubMed ID: 25656402
[TBL] [Abstract][Full Text] [Related]
22. TFE3 controls lipid metabolism in adipose tissue of male mice by suppressing lipolysis and thermogenesis.
Fujimoto Y; Nakagawa Y; Satoh A; Okuda K; Shingyouchi A; Naka A; Matsuzaka T; Iwasaki H; Kobayashi K; Yahagi N; Shimada M; Yatoh S; Suzuki H; Yogosawa S; Izumi T; Sone H; Urayama O; Yamada N; Shimano H
Endocrinology; 2013 Oct; 154(10):3577-88. PubMed ID: 23885019
[TBL] [Abstract][Full Text] [Related]
23. Investigations of the endocannabinoid system in adipose tissue: effects of obesity/ weight loss and treatment options.
Bennetzen MF
Dan Med Bull; 2011 Apr; 58(4):B4269. PubMed ID: 21466769
[TBL] [Abstract][Full Text] [Related]
24. CB1 Receptor-Dependent and Independent Induction of Lipolysis in Primary Rat Adipocytes by the Inverse Agonist Rimonabant (SR141716A).
Müller GA; Herling AW; Wied S; Müller TD
Molecules; 2020 Feb; 25(4):. PubMed ID: 32085406
[TBL] [Abstract][Full Text] [Related]
25. Stimulation of mitochondrial oxidative capacity in white fat independent of UCP1: a key to lean phenotype.
Flachs P; Rossmeisl M; Kuda O; Kopecky J
Biochim Biophys Acta; 2013 May; 1831(5):986-1003. PubMed ID: 23454373
[TBL] [Abstract][Full Text] [Related]
26. The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance.
Jbilo O; Ravinet-Trillou C; Arnone M; Buisson I; Bribes E; Péleraux A; Pénarier G; Soubrié P; Le Fur G; Galiègue S; Casellas P
FASEB J; 2005 Sep; 19(11):1567-9. PubMed ID: 16009704
[TBL] [Abstract][Full Text] [Related]
27. Endocannabinoids regulate adipokine production and the immune balance of omental adipose tissue in human obesity.
Ge Q; Maury E; Rycken L; Gérard J; Noël L; Detry R; Navez B; Brichard SM
Int J Obes (Lond); 2013 Jun; 37(6):874-80. PubMed ID: 22868830
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia training improves hepatic steatosis partly by downregulation of CB1 receptor in obese mice.
Yang Q; Sun S; Liu W; Liu Q; Wang J
Biochem Biophys Res Commun; 2020 May; 525(3):639-645. PubMed ID: 32122652
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional cofactor TBLR1 controls lipid mobilization in white adipose tissue.
Rohm M; Sommerfeld A; Strzoda D; Jones A; Sijmonsma TP; Rudofsky G; Wolfrum C; Sticht C; Gretz N; Zeyda M; Leitner L; Nawroth PP; Stulnig TM; Berriel Diaz M; Vegiopoulos A; Herzig S
Cell Metab; 2013 Apr; 17(4):575-85. PubMed ID: 23499424
[TBL] [Abstract][Full Text] [Related]
30. Hepatic and adipose tissue depot-specific changes in lipid metabolism in Late-onset Obese (LOB) rats.
Frick F; Hume R; Robinson IC; Edén S; Oscarsson J
Lipids; 2008 Apr; 43(4):313-24. PubMed ID: 18335266
[TBL] [Abstract][Full Text] [Related]
31. MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future.
Simon V; Cota D
Eur J Endocrinol; 2017 Jun; 176(6):R309-R324. PubMed ID: 28246151
[TBL] [Abstract][Full Text] [Related]
32. Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake.
Cedó L; Santos D; Roglans N; Julve J; Pallarès V; Rivas-Urbina A; Llorente-Cortes V; Laguna JC; Blanco-Vaca F; Escolà-Gil JC
PLoS One; 2017; 12(12):e0189834. PubMed ID: 29244870
[TBL] [Abstract][Full Text] [Related]
33. Immune-mediated activation of the endocannabinoid system in visceral adipose tissue in obesity.
Kempf K; Hector J; Strate T; Schwarzloh B; Rose B; Herder C; Martin S; Algenstaedt P
Horm Metab Res; 2007 Aug; 39(8):596-600. PubMed ID: 17712725
[TBL] [Abstract][Full Text] [Related]
34. Endocannabinoid system: An overview of its potential in current medical practice.
Mouslech Z; Valla V
Neuro Endocrinol Lett; 2009; 30(2):153-79. PubMed ID: 19675519
[TBL] [Abstract][Full Text] [Related]
35. Activation of GCN2 in macrophages promotes white adipose tissue browning and lipolysis under leucine deprivation.
Wang F; Xiao F; Du L; Niu Y; Yin H; Zhou Z; Jiang X; Jiang H; Yuan F; Liu K; Chen S; Duan S; Guo F
FASEB J; 2021 Jun; 35(6):e21652. PubMed ID: 34004054
[TBL] [Abstract][Full Text] [Related]
36. Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss.
Divoux A; Tordjman J; Lacasa D; Veyrie N; Hugol D; Aissat A; Basdevant A; Guerre-Millo M; Poitou C; Zucker JD; Bedossa P; Clément K
Diabetes; 2010 Nov; 59(11):2817-25. PubMed ID: 20713683
[TBL] [Abstract][Full Text] [Related]
37. Prostaglandin E2 receptor EP3 regulates both adipogenesis and lipolysis in mouse white adipose tissue.
Xu H; Fu JL; Miao YF; Wang CJ; Han QF; Li S; Huang SZ; Du SN; Qiu YX; Yang JC; Gustafsson JÅ; Breyer RM; Zheng F; Wang NP; Zhang XY; Guan YF
J Mol Cell Biol; 2016 Dec; 8(6):518-529. PubMed ID: 27436752
[TBL] [Abstract][Full Text] [Related]
38. Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader-Willi syndrome.
Knani I; Earley BJ; Udi S; Nemirovski A; Hadar R; Gammal A; Cinar R; Hirsch HJ; Pollak Y; Gross I; Eldar-Geva T; Reyes-Capo DP; Han JC; Haqq AM; Gross-Tsur V; Wevrick R; Tam J
Mol Metab; 2016 Dec; 5(12):1187-1199. PubMed ID: 27900261
[TBL] [Abstract][Full Text] [Related]
39. CB
O'Keefe L; Vu T; Simcocks AC; Jenkin KA; Mathai ML; Hryciw DH; Hutchinson DS; McAinch AJ
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232744
[TBL] [Abstract][Full Text] [Related]
40. Electroconvulsive seizures lead to lipolytic-induced gene expression changes in mediobasal hypothalamus and decreased white adipose tissue mass.
Takefusa M; Kubo Y; Ohno M; Segi-Nishida E
Neuropsychopharmacol Rep; 2021 Mar; 41(1):56-64. PubMed ID: 33426813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
